Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Marketing of unproven stem cell-based interventions: A call to action.

Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaag0426. doi: 10.1126/scitranslmed.aag0426. Review.

3.

Synthetic biology and intellectual property rights: six recommendations.

Minssen T, Rutz B, van Zimmeren E.

Biotechnol J. 2015 Feb;10(2):236-41. doi: 10.1002/biot.201400604. Epub 2015 Feb 9.

PMID:
25676051
4.

Patent pools and clearinghouses in the life sciences.

van Zimmeren E, Vanneste S, Matthijs G, Vanhaverbeke W, Van Overwalle G.

Trends Biotechnol. 2011 Nov;29(11):569-76. doi: 10.1016/j.tibtech.2011.06.002. Epub 2011 Jul 4. Review.

PMID:
21733589
5.

A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?

van Zimmeren E, Verbeure B, Matthijs G, Van Overwalle G.

Bull World Health Organ. 2006 May;84(5):352-9. Epub 2006 May 17.

6.

Patent pools and diagnostic testing.

Verbeure B, van Zimmeren E, Matthijs G, Van Overwalle G.

Trends Biotechnol. 2006 Mar;24(3):115-20. Epub 2006 Jan 27. Review.

PMID:
16443296
7.

Models for facilitating access to patents on genetic inventions.

Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G.

Nat Rev Genet. 2006 Feb;7(2):143-8. doi: 10.1038/nrg1765. Review.

PMID:
16385347

Supplemental Content

Loading ...
Support Center